The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 12, 2019

Filed:

Aug. 15, 2014
Applicant:

The University of Kansas, Lawrence, KS (US);

Inventors:

Sunil Abraham David, Lawrence, KS (US);

Euna Yoo, Lawrence, KS (US);

Nikunj Shukla, Lawrence, KS (US);

Alex Christopher Salyer, Lawrence, KS (US);

Mallesh Beesu, Lawrence, KS (US);

Subbalakshmi S. Malladi, Lawrence, KS (US);

Cassandra Jones, Lawrence, KS (US);

Assignee:

The University of Kansas, Lawrence, KS (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 471/04 (2006.01); A61K 39/39 (2006.01); C07D 235/30 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39 (2013.01); C07D 235/30 (2013.01); C07D 471/04 (2013.01); A61K 2039/55511 (2013.01);
Abstract

Compounds described herein can be used for therapeutic purposes. The compounds can be TLR agonists, such as TLR7 or TLR8 agonists. The compounds can be included in pharmaceutical compositions and used for therapies were being a TLR agonist is useful. The pharmaceutical compositions can include any ingredients, such as carries, diluents, excipients, fillers or the like that are common in pharmaceutical compositions. The compounds can be those illustrated or described herein as well as derivative thereof, prodrug thereof, salt thereof, or stereoisomer thereof, or having any chirality at any chiral center, or tautomer, polymorph, solvate, or combinations thereof. As such, the compounds can be used as adjuvants in vaccines as well as for other therapeutic purposes described herein. The compounds can have any one of the formulae. Examples of the compounds can be reviewed in Table 1 and Table A1 for activates.


Find Patent Forward Citations

Loading…